Varian Medical Syste
VAR
Delayed Nyse - 06/22 10:03:47 pm
118.4USD
+0.99%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period September 20172018
Sales2 6682 830
EBITDA-574
Operating profit (EBIT)437513
Pre-Tax Profit (EBT)--
Net income257251
EPS ( $ )2,751,81
Dividend per Share ( $ )--
Yield--
Announcement Date10/25/2017
08:02pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period September 20172018
Debt--
Finance366728
Operating income (EBITDA)-574
Leverage
(Debt/EBITDA)
--
Capital Expenditure59,149,6
Book Value Per Share (BVPS)--
Cash Flow per Share-6,98 $
Announcement Date10/25/2017
08:02pm
-
Balance Sheet Analysis
Financial Ratios
Size 2018e 2019e
Capitalization 10 834 M$ -
Entreprise Value (EV) 10 106 M$ 9 870 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 65,6x 24,9x
Capitalization / Revenue 3,83x 3,65x
EV / Revenue 3,57x 3,33x
EV / EBITDA 17,6x 15,7x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 18,1% 18,7%
operating Leverage (Delta EBIT / Delta Sales) 2,90x 1,70x
Net Margin (Net Profit / Revenue) 8,89% 15,2%
ROA (Net Profit / Asset) 8,70% 12,3%
ROE (Net Profit / Equities) 18,9% 26,4%
Rate of Dividend - -
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   1,75% 2,13%
Cash Flow / Sales 22,6% 17,8%
Capital Intensity (Assets / Sales) 1,02x 1,24x
Financial Leverage (Net Debt / EBITDA) -1,27x -1,53x
Price Earning Ratio
BNA & Dividende